LINC01423
gene geneOn this page
Summary
LINC01423 (long intergenic non-protein coding RNA 1423, HGNC:50732) is a long non-coding RNA gene on chromosome 21q22.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50732 |
| Approved symbol | LINC01423 |
| Name | long intergenic non-protein coding RNA 1423 |
| Location | 21q22.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000231231 |
| Ensembl biotype | lncRNA |
| Entrez | 102724678 |
| RNAcentral | URS000075C33E — lncRNA, 621 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 lncRNA
ENST00000414189, ENST00000436845
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000414189 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001595871 | 38332962 | 38333032 |
| ENSE00001639894 | 38323635 | 38323898 |
| ENSE00001668823 | 38333316 | 38333364 |
| ENSE00001671015 | 38332426 | 38332477 |
| ENSE00001784646 | 38325783 | 38325954 |
Expression profiles
Bgee: expression breadth ubiquitous, 105 present calls, max score 84.29.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4737 / max 45.9858, expressed in 94 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 190451 | 0.2563 | 71 |
| 190453 | 0.1403 | 52 |
| 190452 | 0.0771 | 43 |
Top tissues by expression
105 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.29 | gold quality |
| right lung | UBERON:0002167 | 68.25 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.02 | gold quality |
| sural nerve | UBERON:0015488 | 65.40 | gold quality |
| lymph node | UBERON:0000029 | 64.85 | gold quality |
| calcaneal tendon | UBERON:0003701 | 62.50 | gold quality |
| ascending aorta | UBERON:0001496 | 62.13 | gold quality |
| thyroid gland | UBERON:0002046 | 62.04 | gold quality |
| thoracic aorta | UBERON:0001515 | 62.02 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 61.36 | gold quality |
| popliteal artery | UBERON:0002250 | 61.25 | gold quality |
| tibial artery | UBERON:0007610 | 61.22 | gold quality |
| monocyte | CL:0000576 | 58.56 | gold quality |
| blood | UBERON:0000178 | 56.93 | gold quality |
| vermiform appendix | UBERON:0001154 | 56.90 | gold quality |
| metanephros cortex | UBERON:0010533 | 56.75 | gold quality |
| cortex of kidney | UBERON:0001225 | 56.11 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 55.73 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 55.22 | gold quality |
| islet of Langerhans | UBERON:0000006 | 54.99 | gold quality |
| bone marrow | UBERON:0002371 | 54.90 | gold quality |
| endometrium | UBERON:0001295 | 53.36 | gold quality |
| left coronary artery | UBERON:0001626 | 53.21 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 53.13 | gold quality |
| duodenum | UBERON:0002114 | 53.00 | gold quality |
| prefrontal cortex | UBERON:0000451 | 52.82 | gold quality |
| primary visual cortex | UBERON:0002436 | 52.60 | gold quality |
| lung | UBERON:0002048 | 52.59 | gold quality |
| right coronary artery | UBERON:0001625 | 52.33 | gold quality |
| urinary bladder | UBERON:0001255 | 51.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.95 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.